Automated procedures are increasingly used by companies in all stages of the manufacturing process. As a result, key decisions and actions are being taken through electronic interfaces and many records are being generated electronically. Companies in industries regulated by the United States Food and Drug Administration (FDA), who choose to use systems which utilize electronic records and electronic signatures to replace the paper records and handwritten signatures currently required by FDA regulation, must comply with Title 21 Code of Federal Regulations (21 CFR Part 11) Electronic Records; Electronic Signatures. 21 CFR Part 11 document outlines specific controls on the use of electronic records and electronic signatures, because the FDA believes that the risks of falsification, misinterpretation, and alteration without leaving evidence are higher with electronic records than with paper records.
In this release user can generate reports on the data captured by transaction history. The reports generated in this enhancement should be functionally and visually similar to the transaction history reports.

Role: Designer & Programmer.
Duration: 3 Months.
Client: Catalyst, Milwakee.